Sridharan S Appointed Executive VP at Intas
Intas Pharmaceuticals appoints Sridharan S as Executive VP of API Operations to enhance operational excellence.


Intas Pharmaceuticals is pleased to announce the appointment of Sridharan S as the new Executive Vice President of API Operations. With a distinguished 28-year career, Sridharan brings extensive expertise in various domains, including API manufacturing, production management, process improvement, quality assurance, and resource optimization. His deep knowledge in these areas is anticipated to significantly bolster Intas’s operational excellence and drive the company's ongoing success.
In his new role, Sridharan will be instrumental in enhancing the efficiency and quality of API operations, ensuring that the organization continues to meet the high standards expected in the pharmaceutical industry. His leadership will guide teams towards achieving strategic goals and implementing innovative practices that improve productivity and quality.
As he embarks on this exciting new journey, everyone at Intas Pharmaceuticals extends their heartfelt congratulations to Sridharan. The company is eager to witness the positive impact he will undoubtedly have on the organization and looks forward to his contributions as he takes on these important responsibilities. Wishing him great success in his new role!

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
More from Pharma News
All stories →
Bristol-Myers Squibb Gains FDA Accelerated Approval for Iberdomide in Relapsed or Refractory Multiple Myeloma

Eton Pharmaceuticals Gains FDA Fast Track for AMGLIDIA and Targets 2027 NDA with ASN-001 Acquisition

Discussion